TORONTO, ONTARIO, July 06, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS.TO) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that the Company has further adjourned its annual general and special meeting of shareholders (the "Meeting"). The Meeting was originally held on June 21, 2022, and was reconvened and further adjourned today prior to shareholders voting on the proposed consolidation of the Company’s common shares (the "Share Consolidation").
Aeterna Zentaris Announces Further Adjournment of Shareholder Meeting
Globe Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
